Skip to main content
. 2023 Jul 25;49(4):233–240. doi: 10.1136/rapm-2023-104639

Table 2.

Multimodal and holistic treatment response—breadth of response

3 months 12 months 24 months
Closed-loop SCS Open-loop SCS Closed-loop SCS Open-loop SCS Closed-loop SCS Open-loop SCS
Multimodal treatment responders (MCID in at least two impaired domains out of VAS≥30%, ODI≥10, EQ-5D≥0.074, PSQI≥3, POMS≥10)
 Responders in ≥1 impaired domain (%) 63/67 (94.0) 58/67 (86.6) 63/67 (94.0) 56/67 (83.6) 63/67 (94.0) 56/67 (83.6)
 Responders in ≥2 impaired domains (%) 56/67 (83.6) 51/67 (76.1) 55/67 (82.1) 45/67 (67.2) 53/67 (79.1) 45/67 (67.2)
 Responders in ≥3 impaired domains (%) 54/67 (80.6) 46/67 (68.7) 49/67 (73.1) 39/67 (58.2) 47/67 (70.1) 39/67 (58.2)
 Responders in ≥4 impaired domains (%) 41/66 (62.1) 34/66 (51.5) 41/66 (62.1) 30/66 (45.5) 38/66 (57.6) 27/66 (40.9)
 Responders in five impaired domains (%) 25/44 (56.8) 9/36 (25.0) 28/44 (63.6) 10/36 (27.8) 23/44 (52.3) 6/36 (16.7)
Holistic treatment responder (%) 36/67 (53.7) 26/67 (38.8) 38/67 (56.7) 26/67 (38.8) 33/67 (49.3) 18/67 (26.9)
 Risk difference (%) and 95% CI 14.9 (-1.8, 31.6), p=0.12 17.9 (1.3, 34.6), p=0.06 22.4 (6.4, 38.4), p=0.01

The denominator for the number of patients varies according to the number of domains impaired at baseline.

.MCID, minimal clinical important difference; ODI, Oswestry Disability Index; POMS, Profile of Mood States; PSQI, Pittsburgh Sleep Quality Index; SCS, spinal cord stimulation; VAS, Visual Analog Scale.